The development of a new cholangioscope, the SpyGlass™ Discover (Boston Scientific), has allowed the laparoscopic transcystic common bile duct exploration and stone clearance. The possibility of simultaneous treatment of choledocholithiasis during early laparoscopic cholecystectomy offers the opportunity to enormously reduce the time between acute cholecystitis diagnosis and the execution of cholecystectomy with better outcomes for patients. Furthermore, an altered anatomy of the gastrointestinal tract is not an obstacle to this technique. The aim of the study was to determine whether this new procedure is feasible, safe, and effective. The investigation employs a retrospective case series study including all consecutive patients with a diagnosis of common bile duct stones undergoing cholecystectomy and intraoperative laparoscopic common bile duct clearance using SpyGlass™ Discover at IRCCS Policlinico San Matteo in Pavia (Italy). Eighteen patients were included from May 2022 to May 2023. A complete clearance of the common bile duct was obtained in 88.9% of patients. The mean postoperative length of stay was 3 days. No major complications occurred. After a median follow-up of 8 months, no recurrence of biliary events or readmissions occurred. This procedure has proven to be feasible, safe, and effective.

中文翻译：

---

在急诊和择期胆囊切除术中使用 SpyGlass™ 进行术中经囊腹腔镜胆总管结石清除：单中心病例系列


新型胆管镜 SpyGlass™ Discover（波士顿科学公司）的开发使得腹腔镜经囊胆总管探查和结石清除成为可能。在早期腹腔镜胆囊切除术期间同时治疗胆总管结石的可能性提供了极大缩短急性胆囊炎诊断和执行胆囊切除术之间的时间的机会，从而为患者带来更好的结果。此外，胃肠道解剖结构的改变并不是该技术的障碍。该研究的目的是确定这种新手术是否可行、安全和有效。该调查采用回顾性病例系列研究，包括在帕维亚（意大利）IRCCS Policlinico San Matteo 医院使用 SpyGlass™ Discover 进行胆囊切除术和术中腹腔镜胆总管清除术的所有被诊断为胆总管结石的连续患者。 2022年5月至2023年5月期间纳入了18名患者。88.9%的患者实现了胆总管的完全清除。术后平均住院时间为3天。没有发生重大并发症。中位随访 8 个月后，没有发生胆道事件复发或再入院。事实证明，该手术是可行、安全、有效的。